Increased prevalence of Human Polyomavirus JC viruria in Chronic Inflammatory Rheumatic Diseases patients in treatment with anti-TNF α: a 18 month follow-up study.

Increased prevalence of Human Polyomavirus JC viruria in Chronic Inflammatory Rheumatic Diseases patients in treatment with anti-TNF α: a 18 month follow-up study.

Chronic inflammatory rheumatic diseases (CIRDs) are immune-mediated pathologies involving joints. To date, TNFα-blocking agents administration is the most promising therapy, although these treatments are associated with an increased Polyomavirus JC (JCPyV) reactivation, the aetiological agent of the...

Full description

Bibliographic Details
Main Authors: Donatella Maria Rodio, Elena eAnzivino, Monica eMischitelli, Anna eBellizzi, Rossana eScrivo, Daniela eScribano, Gianlorenzo eConte, Carla ePrezioso, Maria eTrancassini, Guido eValesini, Anna Teresa ePalamara, Valeria ePietropaolo
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-05-01
Series:Frontiers in Microbiology
Subjects:
anti-TNF-α
Chronic inflammatory rheumatic diseases
NCCR
Human Polyomavirus JC
VP1.
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00672/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00672/full

Similar Items